HHT: A Rare Disease with A Broad Spectrum of Clinical Aspects
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
1217-1220
Author(s):
C. Sabba, M. Gallitelli, G. Pasculli, P. Suppressa, F. Resta and E. Tafaro
Molecular and Cellular Regulators of Cancer Angiogenesis
Journal:
Current Cancer Drug Targets
Volume:
7
Page:
743-758
Author(s):
P. P. Goh, D. M. Sze and B. D. Roufogalis
Hereditary Haemorrhagic Telangiectasia: A Rare Disease As A Model for the Study of Human Atherosclerosis
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
3656-3664
Author(s):
G. M. Lenato, P. Suppressa, P. Giordano, G. Guanti, E. Guastamacchia, V. Triggiani, L. Amati, F. Resta, V. Covelli, E. Jirillo and C. Sabba
Cellular Targets for Anticancer Strategies
Journal:
Current Drug Targets
Volume:
5
Page:
347-355
Author(s):
Caterina A.M. La Porta
Gene Therapy in Plastic and Reconstructive Surgery
Journal:
Current Gene Therapy
Volume:
5
Page:
81-99
Author(s):
S. Roman, R. Lindeman, G. O'Toole and M. D. Poole
Metabolic and Functional Brain Mapping, Connectivity and Plasticity Applied to the Surgery of Cerebral Tumors
Journal:
Current Medical Imaging
Volume:
1
Page:
131-155
Author(s):
Hugues Duffau
Editorial [Hot Topic: Stroke Prevention (Guest Editors: T. Tatlisumak, K. Rantanen and M. Fisher)]
Journal:
Current Drug Targets
Volume:
8
Page:
784-785
Author(s):
Turgut Tatlisumak, Kirsi Rantanen and Marc Fisher
Matrix Metalloproteinases: New Routes to the Use of MT1-MMP As A Therapeutic Target in Angiogenesis-Related Disease
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
1787-1802
Author(s):
A. G. Arroyo, L. Genis, P. Gonzalo, S. Matias-Roman, A. Pollan and B. G. Galvez
Subject Index To Volume 3
Journal:
Current Neurovascular Research
Volume:
4
Page:
vii-vii
Author(s):
Bentham Science Publishers
Do Not Say Ever Never More: The Ins and Outs of Antiangiogenic Therapies
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
3932-3957
Author(s):
Ana R. Quesada, Miguel Angel Medina, Ramon Munoz-Chapuli and Angel Luis G. Ponce